End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.14 CNY | -0.92% | +0.09% | -19.66% |
Mar. 06 | China Approves Tong Ren Tang Group's Clinical Trial of Heart Failure Drug | MT |
Oct. 30 | Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Sales 2023 * | 18.15B 2.52B | Sales 2024 * | 20.72B 2.88B | Capitalization | 59.17B 8.22B |
---|---|---|---|---|---|
Net income 2023 * | 1.76B 245M | Net income 2024 * | 2.09B 290M | EV / Sales 2023 * | 2.77 x |
Net cash position 2023 * | 8.88B 1.23B | Net cash position 2024 * | 12.69B 1.76B | EV / Sales 2024 * | 2.24 x |
P/E ratio 2023 * |
33.8
x | P/E ratio 2024 * |
28.6
x | Employees | 18,065 |
Yield 2023 * |
0.78% | Yield 2024 * |
0.92% | Free-Float | 47.55% |
1 day | -0.92% | ||
1 week | +0.09% | ||
Current month | -3.06% | ||
1 month | -1.44% | ||
3 months | -16.22% | ||
6 months | -20.16% | ||
Current year | -19.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chao Hua Zhang
CEO | Chief Executive Officer | 50 | 21-06-24 |
Li Yang
BRD | Director/Board Member | 46 | 21-06-24 |
Kai Ting Wen
BRD | Director/Board Member | 46 | 20-04-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qing Ying Yang
BRD | Director/Board Member | 70 | 23-01-08 |
Yi Zang
BRD | Director/Board Member | 47 | 18-06-12 |
Bai Gang Liu
BRD | Director/Board Member | 56 | 18-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 2 M€ | -14.14% | ||
1.07% | 2 M€ | -10.16% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 43.14 | -0.92% | 13,899,160 |
24-03-15 | 43.54 | +0.51% | 6,995,190 |
24-03-14 | 43.32 | -1.21% | 11,019,190 |
24-03-13 | 43.85 | -1.99% | 13,505,080 |
24-03-12 | 44.74 | +3.81% | 22,799,000 |
End-of-day quote Shanghai S.E., March 17, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.66% | 8.22B | |
+30.83% | 687B | |
+30.80% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.06% | 211B | |
-6.99% | 208B | |
-4.03% | 203B | |
-3.72% | 157B |